Xbrane Biopharma

Major Shareholding Notification • Mar 28, 2024

Issuer Xbrane Biopharma AB

Holder

Nordnet AB (publ)

Instrument

Instrument	Aktie SE0007789409
Before the transaction
Shares	Data not given*
Voting rights	Data not given*
Transaction
Reason for major shareholding notification Sell
Date	27/03/2024
Limit for number of shares	5 %
Limit for number of votes	5 %
After the transaction
Quantity
Shares	72,223,044
Directly held voting rights	0
Indirectly held voting rights	72,223,044
Percentage
Directly held shares	4.72205 %
Directly held voting rights	0 %
Indirectly held voting rights	4.72205 %

Resulting distribution of total holdings

	Percentage of voting rights:	Number of underlying shares:
Shares	4.72205 %	72,223,044
Instruments - FITA Ch. 4, section 2, first paragraph, line 2
Instruments - FITA Ch. 4, section 2, first paragraph, line 3
- Physically settled
- Cash settled
Total	4.72205 %	72,223,044
Chain of controlling companies Voting rights % Voting rights Company

71,877,720 4.69948		Nordnet Pensionsförsäkring AB
345,324	0.02257	Nordnet Livsforsikring AS
Group total holdings
Voting rights		72,223,044

Notes (other relevant informations according to law)

Flaggning beräknad på nytt antal aktier och röster (1 529 483 397) efter registrerad företrädes- och ersättningsemission.

Published

28/03/2024 11:21

Percentage of voting rights 4.72205

Contact

Name Felix Mandoki Phone +46766110734 Email felix.mandoki@nordnet.se

*Source of information has chosen not to submit the data

CLOSE PRINT

rapportering@fi.se Tfn 08-408 980 37 Fax 08-24 39 25